An Innocent-Looking Shadow on Her Thumbnail Turned Out to be Subungual Melanoma
Source: https://pixabay.com/en/thumb-up-like-sign-hand-ok-good-441938/

An Innocent-Looking Shadow on Her Thumbnail Turned Out to be Subungual Melanoma

Maria’s message is: “when in doubt, get a biopsy." Ten years ago, Maria Sylvia noticed a vertical streak on her thumbnail that at the time she thought was “cool." She…

Continue Reading An Innocent-Looking Shadow on Her Thumbnail Turned Out to be Subungual Melanoma
Early Weight Loss Linked to Lower Gastroesophageal Junction Carcinoma Survival Rates
source: pixabay.com

Early Weight Loss Linked to Lower Gastroesophageal Junction Carcinoma Survival Rates

Unintended weight loss is a symptom associated with many different forms of cancer. But what can this weight loss tell researchers about the patients and their outcomes? Healio shares a…

Continue Reading Early Weight Loss Linked to Lower Gastroesophageal Junction Carcinoma Survival Rates
First Patient Dosed in WU-CART-007 Trial for Acute Lymphoblastic Leukemia
https://unsplash.com/photos/tV-RX0beDp8

First Patient Dosed in WU-CART-007 Trial for Acute Lymphoblastic Leukemia

Each year, an estimated 11,000 people across the globe are diagnosed with relapsed or refractory (R/R) T-cell acute lymphoblastic leukemia (T-ALL) or lymphoblastic lymphoma (LBL). However, there is only one…

Continue Reading First Patient Dosed in WU-CART-007 Trial for Acute Lymphoblastic Leukemia
ICYMI: First Patient Dosed in TST001 Study for Biliary Tract Cancer
source: pixabay.com

ICYMI: First Patient Dosed in TST001 Study for Biliary Tract Cancer

In late February 2022, biopharmaceutical company Trascenta Holding Limited ("Trascenta") provided an update on its clinical program for TST001, a monoclonal antibody therapy designed for those with locally advanced or…

Continue Reading ICYMI: First Patient Dosed in TST001 Study for Biliary Tract Cancer
Young Adults Diagnosed with Late-Stage Colorectal Cancer at Rising Rates
Source: https://pixabay.com/en/dark-building-young-abandoned-boy-1283752/

Young Adults Diagnosed with Late-Stage Colorectal Cancer at Rising Rates

In the past, some research has suggested that earlier screening for colorectal cancer – also known as rectal or colon cancer – could be beneficial for improving patient outcomes. For…

Continue Reading Young Adults Diagnosed with Late-Stage Colorectal Cancer at Rising Rates

Studies Show Favorable Results For PARP Inhibitors in the Treatment of Advanced Ovarian Cancer

Dr. Rachel Grisham MSK ovarian cancer section head discussed clinical trials investigating PARP inhibitors for ovarian cancer patients. The event was a round table discussion and interview for Targeted Oncology.…

Continue Reading Studies Show Favorable Results For PARP Inhibitors in the Treatment of Advanced Ovarian Cancer
Could Prozac Treat Glioblastoma?
source: pixabay.com

Could Prozac Treat Glioblastoma?

Prozac (fluoxetine) is used to treat a variety of mental health conditions including major depressive disorder (MDD), obsessive-compulsive disorder (OCD), bulimia, and premenstrual dysphoric disorder (PMDD), among others. You may…

Continue Reading Could Prozac Treat Glioblastoma?
ET140203, ECT204 Earn Orphan Drug Designation for Hepatocellular Carcinoma
source: pixabay.com

ET140203, ECT204 Earn Orphan Drug Designation for Hepatocellular Carcinoma

In a news release from early February 2022, clinical-stage biotechnology company Eureka Therapeutics, Inc. (“Eureka”) shared that two of its therapies – ET140203 and ECT204 – received Orphan Drug designation…

Continue Reading ET140203, ECT204 Earn Orphan Drug Designation for Hepatocellular Carcinoma